Published online before print January 6, 2003, doi: 10.1161/01.CIR.0000046449.36178.00
(Circulation. 2003;107:618.)
© 2003 American Heart Association, Inc.
Basic Science Reports |
Myocardial Infarct Expansion and Matrix Metalloproteinase Inhibition
From the Divisions of Cardiothoracic Surgery and Adult Cardiology, Medical University of South Carolina, Charleston.
Correspondence to Francis G. Spinale, MD, PhD, Cardiothoracic Surgery, Strom Thurmond Research Building, 770 MUSC Complex, Suite 625, Medical University of South Carolina, Charleston, SC 29425. E-mail mukherr{at}musc.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— A potential mechanism for left ventricular (LV) remodeling after myocardial infarction (MI) is activation of the matrix metalloproteinases (MMPs). This study examined the effects of MMP inhibition (MMPi) on regional LV geometry and MMP levels after MI.
Methods and Results— In pigs instrumented with radiopaque markers to measure regional myocardial geometry, MI was created by ligating the obtuse marginals of the circumflex artery. In the first study, pigs were randomized to MMPi (n=7; PD166793, 20 mg · kg-1 · d-1) or MI only (n=7) at 5 days after MI, and measurements were performed at 2 weeks. Regional MI areas were equivalent at randomization and were increased in the MI-only group at 2 weeks after MI compared with the MMPi group. In the second study, pigs randomized to MMPi (n=9) or MI only (n=8) were serially followed up for 8 weeks. At 8 weeks after MI, LV end-diastolic dimension was lower with MMPi than in the MI-only group (4.7±0.1 versus 5.1±0.1 cm, P<0.05). Regional MI area was reduced with MMPi at 8 weeks after MI (1.3±0.1 versus 1.7±0.1 cm2, P<0.05). MMPi reduced ex vivo MMP proteolytic activity. In the MI region, membrane-type MMP levels were normalized and levels of the endogenous tissue inhibitor of MMPs (TIMP-1) were increased compared with normal levels with MMPi. These effects were not observed in the MI-only group.
Conclusions— MMPi attenuated the degree of post-MI LV dilation and expansion of the infarct during the late phase of MI healing. In addition, exogenous MMPi caused region-specific modulation of certain MMP and TIMP species.
Key Words: myocardial infarction • metalloproteinases • inhibitors
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Left ventricular (LV) regional myocardial dysfunction and remodeling that occur immediately after myocardial infarction (MI) can persist long after the acute insult.1–6 The summation of cellular and extracellular events that occur in the post-MI period results in changes in LV geometry and has been called "infarct expansion."3–6 Past studies have demonstrated that a structural determinant of infarct expansion is extracellular remodeling.1,5,6 A family of proteolytic enzymes that have been implicated in tissue remodeling are the matrix metalloproteinases (MMPs).7 Increased MMP expression has been reported in patients with end-stage heart failure and in several animal models of developing LV dysfunction.8–16 Increased interstitial MMP activity has been demonstrated to occur directly within the ischemic myocardium.17 Past studies have demonstrated that exogenous MMP inhibition (MMPi) can influence the myocardial remodeling process.13–16 However, the effects of MMPi on infarct expansion during the later phases of post-MI healing remain unknown. Moreover, the effect of post-MI MMPi on regional MMP species expression remains unclear. The present study tested the hypothesis that increased myocardial MMP activation is a contributory mechanism for continued expansion of the healing infarct.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mature Yorkshire pigs (23 to 25 kg, Hambone Farms, Orangeburg, SC) were instrumented to measure the effects of MMP inhibition on global and regional LV geometry after MI. To examine the effects of MMPi in the early and late post-MI periods, this study was performed as 2 substudies. In the first substudy, changes in global LV and regional MI geometry that occurred within 2 weeks after MI were examined. In the second substudy, the effects of sustained MMPi on global and regional MI geometry were measured serially for 8 weeks after MI. Ten weight-matched noninstrumented pigs were used as reference, non-MI controls. All animals were treated and cared for in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Research Council, Washington, 1996).
Substudy 1: Early Post-MI Remodeling
The animals were anesthetized with 2% isoflurane, and an arterial line was placed as described previously.13,17 Through a left thoracotomy, snare occluders were placed loosely around the first 2 obtuse marginals of the circumflex coronary artery (OM1, OM2), and the distal ends of the snare were secured in a subcutaneous pocket. A quadrilateral array of radiopaque markers (1.6 mm) was sutured onto the myocardium between OM1 and OM2, such that the intermarker distance was 1 cm. The markers were oriented on the myocardium such that one of the diagonals was approximately parallel to the LV long axis and the other diagonal was perpendicular to the first.
On the day of MI creation, the animals were sedated with diazepam (20 mg PO). Transthoracic, short-axis echocardiographic studies (3-MHz transducer; Sonos5500, Agilent Technologies) were performed to determine LV endocardial dimensions and LV fractional shortening at the level of the papillary muscles.13 Fluoroscopic images of the myocardial markers were recorded with a high-speed cinefluoroscope (Philips Cardio-Diagnost) and were digitized (ATI Radeon). Using projections of the markers from 2 orthogonal planes, intermarker distances were computed in 3D space18 and used to determine the area circumscribed by the markers. The arterial line was accessed, 20 mL of blood was collected, and mean arterial pressure was monitored. Plasma MMP-2 levels were measured by ELISA.13 The distal ends of the snare were exteriorized, and MI was induced by tightening of the snare. Occlusion of the coronary arteries resulted in discrete, transmural MI of 23±1%.
At 5 days after MI, echocardiographic and fluoroscopic measurements were repeated, blood was collected, and the animals were randomized to remain untreated (n=7) or receive MMPi (n=7, PD166793, 20 mg · kg-1 · d-1 PO). On the basis of ex vivo MMP assays, this dosing regimen for PD166793 has been demonstrated to provide pharmacological MMPi.13 At terminal study (2 weeks after MI), all the above measurements were repeated.
Substudy 2: Late Post-MI Remodeling
The surgical procedure was identical to that described above, with the exception that MI was induced at the time of surgery. Pigs were randomized to remain untreated (n=8) or receive MMPi (n=9) at 5 days after MI. Echocardiographic and fluoroscopic measurements were made at 2-week intervals up to 8 weeks after MI. At the conclusion of the study period, the LV was quickly extirpated. Full-thickness sections from the MI, border (0.5-cm perimeter of the MI), and remote regions were obtained.
LV Myocardial MMP Levels
At 8 weeks after MI, the abundance of MMP-13, MT1-MMP (membrane-type MMP), and the endogenous tissue inhibitors of MMP (TIMP-1 and TIMP-4) were examined by immunoblotting.8,13 Relative LV MMP-2 and MMP-9 levels were examined by use of substrate-specific zymography.8,10,13 Specific ex vivo MMP-2 activity was measured in crude tissue homogenates with an antibody capture assay.13
Data Analysis
Temporal changes in global LV dimensions and regional marker area were compared between the MI groups by 2-way ANOVA. Hemodynamics at terminal study were compared by 1-way ANOVA. For analysis of regional MMP/TIMP levels, values from the myocardial regions were compared against the control values of 100% by a 1-sided t test. Ex vivo MMP-2 activity was compared between myocardial regions and presence of MMPi with a split-plot model. Specific pairwise comparisons were performed by a Bonferroni-adjusted t test. Results are presented as mean±SEM. Values of P<0.05 were considered to be statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Systemic Hemodynamics and Regional Function With Chronic MI: Effects of MMPi
Resting heart rate and mean arterial pressure under conscious ambient conditions were 97±7 bpm and 105±4 mm Hg, respectively, and remained unchanged at 2 weeks and 8 weeks after MI.
Regional and Global LV Remodeling in the Early Post-MI Period: Effects of MMPi
Before MI induction, LV end-diastolic dimension was 4.4±0.1 cm, and fractional shortening was 38±1%. On day 5 after MI and before randomization, LV end-diastolic dimension was higher (5.1±0.1 cm, P<0.05) and fractional shortening lower (28±2%, P<0.05) than pre-MI values, with no difference between the 2 groups. At 2 weeks after MI, LV end-diastolic dimension was increased over pre-MI values by 14±2% (P<0.05) in the MI-only group and by 12±3% (P<0.05) in the MMPi (MI+MMPi) group. The increase in LV end-diastolic dimension from pre-MI values, however, was not different between the 2 groups.
The baseline marker area was 1.00±0.01 cm2 and was not different between the 2 groups. At 5 days after MI and before randomization, marker areas were increased from pre-MI values (Figure 1A), and the rate of increase in marker area was similar between the 2 groups (Figure 1B). At 2 weeks after MI, the extent and rate of change in marker area were lower in the MI+MMPi group than the MI-only group (Figure 1, A and B). Plasma MMP-2 levels (Figure 1C) were similar between the 2 MI groups before randomization. At 2 weeks after MI, plasma MMP-2 levels were increased in the MI-only group.
|
Time-Dependent LV Remodeling in the Late Post-MI Period: Effects of MMPi
At 8 weeks after MI, LV end-diastolic dimensions were lower in the MI+MMPi group than the MI-only group (Figure 2C). In the MI-only group, the wall thinning index4,6 was 0.45±0.06 and was increased in the MI+MMPi group (0.70±0.09, P<0.05).
|
Marker area increased in a time-dependent manner in the post-MI period (Figure 2A). Compared with MI-only values, marker area was reduced in the MI+MMPi group by 2 weeks after MI and remained lower through the post-MI period. The rate of increase in marker area relative to week 2 values was attenuated with MMPi (Figure 2B).
MMP Abundance and Zymographic Levels With Chronic MI: Effects of MMPi
In the remote and border regions, MMP-13 abundance was reduced from controls in both MI groups (MI-only group: remote, 52±6%; border, 62±7%; MI+MMPi group: remote, 64±11%; border 55±10%; P<0.05 versus control level of 100%). MMP-13 abundance in the MI region was lower than in controls in the MI+MMPi group (72±11%, P<0.05).
By substrate-specific zymography, proteolytic bands consistent with that for MMP-9 could be identified in 20 of 42 samples for the MI-only group and in 18 of 54 samples for the MI+MMPi group (
2, P=0.16). In the remote region, detectable MMP-9 levels were lower in the MI+MMPi group than the MI-only group (25 742±9211 versus 82 223±26 418 pixels, P<0.05, Mann-Whitney test). Gelatinolytic bands consistent with that for MMP-2 were detected in all myocardial samples (Figure 3). Compared with the MI-only group, MMP-2 levels in the remote region were reduced with MMPi. In the MI-only group, tissue MMP-2 activity measured as a function of proteolytic product formation (Figure 4) revealed that MMP activity in the MI region was higher than control values. With MMPi, MMP-2 activity at the MI region was lower than that of the MI-only group and was normalized to control values.
|
P<0.05 vs remote region, ¶P<0.05 vs border region.
|
MT1-MMP abundance was significantly higher in the MI region in the MI-only group than reference control values (Figure 5). With MMPi, MT1-MMP abundance was reduced from reference control values in the remote and border regions and was normalized in the MI region. In the MI and border regions, MT1-MMP abundance was lower with MMPi.
|
Prominent bands for TIMP-1 were detected at 28 and 56 kDa. The 56 kDa band was a dimer for TIMP-1 and was analyzed for each region (Figure 6A). TIMP-1 levels were increased over control values in the MI region of the MI+MMPi group. In the remote and MI regions of the MI+MMPi group, TIMP-1 levels were higher than in the MI-only group. In the remote region, TIMP-4 levels were higher in the MI+MMPi group than in the MI-only group (Figure 6B).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
LV remodeling that occurs after MI has been demonstrated to result in progressive LV dilation.2–6 At the infarcted region, alterations in myocardial composition and structure occur after MI6,7 and can lead to infarct thinning and expansion.1,4–7 Because the MMPs are enzymes that influence myocardial remodeling,8–16 the goal of the present study was to examine the relation between MMP activation and infarct expansion. The important and unique findings of this study were that MMPi in the post-MI period attenuated the degree of global LV dilation, which was a direct result of a reduction in the extent and rate of infarct expansion during the later phase of post-MI healing. Contributory mechanisms for these LV remodeling effects with MMPi after MI were 2-fold. First, there was a direct pharmacological inhibitory effect on MMP activity in the MI region. Second, post-MI MMPi caused region-specific modulation of certain species of MMPs and TIMPs. Thus, these results demonstrate that localized alterations in MMP/TIMP levels are a contributory mechanism for late expansion of the healing infarct.
Infarct sizes obtained in the present study are consistent with those reported previously.2,4 Moreover, similar MI size in patients was associated with post-MI LV dilation.2,3 Therefore, in the present study, MI induction in pigs most likely recapitulated a commonly encountered clinical phenotype of post-MI remodeling. However, it must be recognized that the location and size of the MI may play an important role in the determination of post-MI LV remodeling and LV function and/or dysfunction in the post-MI period.6 For example, in a past report, Jugdutt6 reported that infarcts created in the anterior LV wall were associated with a greater degree of LV dilation and infarct expansion than infarcts in the posterior LV created by occlusion of the circumflex artery. In the present study, the size and location of the MI were chosen to prevent acute changes in ejection performance and systemic hemodynamics. Nevertheless, future studies are warranted to examine the effects of MMPi on post-MI LV remodeling that is superimposed with reduced ejection performance and the effect of infarct location.
The rationale for selecting the duration and the initiation of MMPi in the post-MI period was based on past observations.16,19–21 In a mouse model of MI, Rohde et al16 demonstrated that MMPi instituted immediately after MI attenuated the degree of LV dilation that occurred over a period of 4 days after MI. However, a previous study demonstrated that the levels of various MMP species can remain elevated for several weeks in the post-MI period.12 Therefore, the present study was performed to define the spatiotemporal relationship between regional MI and chamber remodeling with prolonged MMPi. MMPi instituted at 5 days after MI reduced regional MI size and expansion rate by 2 weeks, and these effects persisted when treatment was continued for up to 2 months. Furthermore, the early attenuation of regional MI expansion was translated to a reduction in LV chamber dilation at 2 months after MI.
The gelatinases, such as MMP-2 and MMP-9, proteolytically process fibrillar collagen fragments and other critical basement membrane proteins of the extracellular matrix.8,13 In the remote myocardium, zymographic MMP-2 levels were reduced with MMPi. Therefore, this observation suggests that MMPi modulated MMP-2 levels in a region-specific manner after MI, which in turn would probably influence interstitial proteins such as basement membrane components. MMP-9 was variably expressed within the myocardium at 8 weeks after MI. Levels of the collagenase MMP-13 were reduced from control values in the viable myocardium at 8 weeks after MI. Because MMP-9 and MMP-13 abundance in the post-MI myocardium has been demonstrated to increase early after MI and then decrease later in the healing process,12 the reduction in the levels of these MMP species at 8 weeks after MI may be a result of a time-dependent response in the post-MI period. The MT-MMPs have been demonstrated to degrade components of the extracellular matrix and activate other MMPs.10 In the present study, the relative reduction in MT1-MMP levels with MMPi may have reduced the degree of pericellular matrix degradation and reduced the activational state of other MMP species.
The TIMPs provide endogenous control of MMP activity.9,10,12,14 TIMP-1 and TIMP-4 have been demonstrated to be present in the myocardium.9,10 In the present study, exogenous MMPi was associated with increased TIMP-1 abundance after MI, suggesting that pharmacological MMPi increased TIMP-1–mediated MMP regulation. However, TIMP-4 abundance appeared to be reduced in the post-MI myocardium. Interestingly, chronic MMPi was associated with a region-specific increase in TIMP-4 levels in the region remote to the MI. The region-specific changes in MMP/TIMP levels with pharmacological MMPi puts forth the intriguing possibility that exogenous MMPi may actually influence endogenous synthesis and release of MMP/TIMP species in the post-MI period. Nevertheless, it must be recognized that TIMP-2 levels were not measured in the present study. Because past studies have demonstrated that time-dependent changes in TIMP-2 levels can occur after MI,12,22 the effects of MMPi on TIMP-2 expression in the post-MI setting warrant further investigation.
In the present study, regional ex vivo MMP-2 proteolytic activity was higher in the MI region than in controls. In contrast, chronic MMPi reduced ex vivo MMP activity within the MI region, thereby confirming that local pharmacological MMPi was achieved. Because broad-spectrum MMPi was used in the present study, the question of which MMP species were causative in the post-MI LV remodeling process remains unclear. Therefore, identification of those MMP species that emerge in LV remodeling after MI would be necessary to develop more targeted MMPi.
Study Limitations and Summary
In the present study, transthoracic echocardiograms were used to serially determine global LV geometry in the post-MI period. Although these measurements provided information on LV dimensions and fractional shortening, computations of LV volumes based on multiple short-axis sections or apical views could not be performed. Consequently, changes in LV geometry in the peri-MI region, ie, bulging or expansion indices,4,6 were not determined.
A well-defined temporal sequence of cellular and extracellular events occurs after acute MI and determines the initial wound-healing response.5–7 The early, or acute, phase of post-MI wound healing is associated with structural remodeling and neutrophil infiltration within the infarcted myocardium.5,6 Early abrogation of MMP activity, either through genetic modification or pharmacologically, has been associated with abnormalities in the post-MI wound-healing response.19–21 Accordingly, the present study deployed MMPi 5 days after MI to avoid the confounding influences surrounding the acute phase of an MI and the potential deleterious effects of early modulation of MMP activity. Because MMPi was instituted at 5 days after MI, it is unlikely that this pharmacological approach resulted in significant myocardial salvage within the MI region. Rather, it is likely that MMPi reduced MMP activation within the border zone of the MI and may have contributed to the attenuation in infarct expansion. However, because myocardial MMP/TIMP levels were not measured in the early post-MI period, this issue remains speculative and warrants further investigation. Finally, it must be recognized that these studies were performed in an animal model of MI, and future studies must be performed to further elucidate the mechanistic aspects of MMPi in the post-MI setting. Nevertheless, the unique results of the present study provide proof of concept that post-MI MMPi can attenuate the extent and rate of infarct expansion and modify local MMP/TIMP species expression during the late phase of post-MI healing.
|
Acknowledgments |
|---|
This study was supported by National Heart, Lung, and Blood Institute grants HL-45024, HL-97012, and PO1-48788. The authors acknowledge Dr Mary K. King, Jeffrey A. Sample, Colin E. Widener, Robert E. Stroud, Seth I. Christian, and Jennifer W. Hendrick for assisting with this project. We thank Dr J. Thomas Peterson for the gift of the MMP inhibitor.
Received July 31, 2002; revision received October 14, 2002; accepted October 14, 2002.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990; 81: 1161–1172.
2. Chareonthaitawee P, Christian TF, Hirose K, et al. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995; 25: 567–573.[Abstract]
3. St John Sutton M, Pfeffer MA, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Circulation. 1997; 96: 3294–3299.
4. Jugdutt BI, Michorowski BL. Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: a two-dimensional echocardiographic study. Clin Cardiol. 1987; 10: 641–652.[Medline] [Order article via Infotrieve]
5. St John Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction. Circulation. 2000; 101: 2981–2988.
6. Jugdutt BI. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol. 1995; 25: 1718–1725.[Abstract]
7. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res. 2000; 46: 250–256.
8. Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 1998; 97: 1708–1715.
9. Li YY, Feldman AM, Sun Y, et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation. 1998; 98: 1728–1734.
10. Spinale FG, Coker ML, Heung LJ, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000; 102: 1944–1949.
11. Coker ML, Doscher MA, Thomas CV, et al. Matrix metalloproteinase activity and expression in isolated LV myocyte preparations. Am J Physiol. 1999; 277: H777–H787.[Medline] [Order article via Infotrieve]
12. Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloproteinase and tissue inhibitor during heart failure progression in the infarcted rat. Cardiovasc Res. 2000; 46: 307–315.
13. Spinale FG, Krombach RS, Coker ML, et al. Matrix metalloproteinase inhibition during developing congestive heart failure in pigs: effects on left ventricular geometry and function. Circ Res. 1999; 85: 364–376.
14. Li H, Simon H, Bocan TMA, et al. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effects of ACE- and MMP inhibition. Cardiovasc Res. 1999; 46: 298–306.
15. Peterson JT, Hallak H, Johnson L, et al. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation. 2001; 103: 2303–2309.
16. Rohde LE, Ducharme A, Arroyo LH, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation. 1999; 99: 3063–3070.
17. Etoh T, Joffs C, Deschamps AM, et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol. 2001; 281: H987–H994.
18. Moon MR, Castro LJ, DeAnda A, et al. Right ventricular dynamics during left ventricular assistance in closed-chest dogs. Ann Thorac Surg. 1993; 56: 54–67.[Abstract]
19. Ducharme A, Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000; 106: 55–62.[Medline] [Order article via Infotrieve]
20. Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999; 5: 1135–1142.[CrossRef][Medline] [Order article via Infotrieve]
21. Creemers E, Cleutjens J, Smits J, et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol. 2000; 156: 1865–1873.
22. Deten A, Holzl A, Leicht M, et al. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001; 33: 1191–1207.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  J. A. Dixon and F. G. Spinale Large Animal Models of Heart Failure: A Critical Link in the Translation of Basic Science to Clinical Practice Circ Heart Fail, May 1, 2009; 2(3): 262 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Timmers, J. K. van Keulen, I. E. Hoefer, M. F.L. Meijs, B. van Middelaar, K. den Ouden, C. J.A. van Echteld, G. Pasterkamp, and D. P.V. de Kleijn Targeted Deletion of Nuclear Factor {kappa}B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction Circ. Res., March 13, 2009; 104(5): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mukherjee, J. A. Zavadzkas, S. M. Saunders, J. E. McLean, L. B. Jeffords, C. Beck, R. E. Stroud, A. M. Leone, C. N. Koval, W. T. Rivers, et al. Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs Ann. Thorac. Surg., October 1, 2008; 86(4): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Westermann, J. Mersmann, A. Melchior, T. Freudenberger, C. Petrik, L. Schaefer, R. Lullmann-Rauch, O. Lettau, C. Jacoby, J. Schrader, et al. Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction Circulation, March 11, 2008; 117(10): 1269 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Timmers, J. P.G. Sluijter, J. K. van Keulen, I. E. Hoefer, M. G.J. Nederhoff, M.-J. Goumans, P. A. Doevendans, C. J.A. van Echteld, J. A. Joles, P. H. Quax, et al. Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction Circ. Res., February 1, 2008; 102(2): 257 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Uemura, M. Li, T. Tsutsumi, T. Yamazaki, T. Kawada, A. Kamiya, M. Inagaki, K. Sunagawa, and M. Sugimachi Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2254 - H2261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Pleger, P. Most, M. Boucher, S. Soltys, J. K. Chuprun, W. Pleger, E. Gao, A. Dasgupta, G. Rengo, A. Remppis, et al. Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue Circulation, May 15, 2007; 115(19): 2506 - 2515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Nguyen, A. Cheng, F. A. Tibayan, D. Liang, G. T. Daughters, N. B. Ingels Jr., and D. C. Miller Septal-lateral annnular cinching perturbs basal left ventricular transmural strains Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Nguyen, A. Cheng, F. Langer, F. Rodriguez, R. A. Oakes, A. Itoh, D. B. Ennis, D. Liang, G. T. Daughters, N. B. Ingels Jr, et al. Altered Myocardial Shear Strains Are Associated With Chronic Ischemic Mitral Regurgitation Ann. Thorac. Surg., January 1, 2007; 83(1): 47 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mukherjee, J. T. Mingoia, J. A. Bruce, J. S. Austin, R. E. Stroud, G. P. Escobar, D. M. McClister Jr, C. M. Allen, M. A. Alfonso-Jaume, M. E. Fini, et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2216 - H2228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ernens, D. Rouy, E. Velot, Y. Devaux, and D. R. Wagner Adenosine Inhibits Matrix Metalloproteinase-9 Secretion By Neutrophils: Implication of A2a Receptor and cAMP/PKA/Ca2+ Pathway Circ. Res., September 15, 2006; 99(6): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Webb, D. D. Bonnema, S. H. Ahmed, A. H. Leonardi, C. D. McClure, L. L. Clark, R. E. Stroud, W. C. Corn, L. Finklea, M. R. Zile, et al. Specific Temporal Profile of Matrix Metalloproteinase Release Occurs in Patients After Myocardial Infarction: Relation to Left Ventricular Remodeling Circulation, September 5, 2006; 114(10): 1020 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale, G. P. Escobar, J. W. Hendrick, L. L. Clark, S. S. Camens, J. P. Mingoia, C. G. Squires, R. E. Stroud, and J. S. Ikonomidis Chronic Matrix Metalloproteinase Inhibition Following Myocardial Infarction in Mice: Differential Effects on Short and Long-Term Survival J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 966 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Hudson, P. W. Armstrong, W. Ruzyllo, J. Brum, L. Cusmano, P. Krzeski, R. Lyon, M. Quinones, P. Theroux, D. Sydlowski, et al. Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction: Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) Trial J. Am. Coll. Cardiol., July 4, 2006; 48(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Mauro, G. Di Giammarco, G. Vitolla, M. Contini, A. L. Iaco, A. Bivona, L. Weltert, and A. M. Calafiore Impact of No-to-Moderate Mitral Regurgitation on Late Results After Isolated Coronary Artery Bypass Grafting in Patients With Ischemic Cardiomyopathy Ann. Thorac. Surg., June 1, 2006; 81(6): 2128 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Janssens and H. R. Lijnen What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res, February 15, 2006; 69(3): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window Cardiovasc Res, February 15, 2006; 69(3): 604 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Miner and W. L. Miller A Look Between the Cardiomyocytes: The Extracellular Matrix in Heart Failure Mayo Clin. Proc., January 1, 2006; 81(1): 71 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Su, F. G. Spinale, L. W. Dobrucki, J. Song, J. Hua, S. Sweterlitsch, D. P. Dione, P. Cavaliere, C. Chow, B. N. Bourke, et al. Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling Circulation, November 15, 2005; 112(20): 3157 - 3167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Blom, R. Mukherjee, J. J. Pilla, A. S. Lowry, W. M. Yarbrough, J. T. Mingoia, J. W. Hendrick, R. E. Stroud, J. E. McLean, J. Affuso, et al. Cardiac Support Device Modifies Left Ventricular Geometry and Myocardial Structure After Myocardial Infarction Circulation, August 30, 2005; 112(9): 1274 - 1283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Ikonomidis, J. R. Barbour, Z. Amani, R. E. Stroud, A. R. Herron, D. M. McClister Jr, S. E. Camens, M. L. Lindsey, R. Mukherjee, and F. G. Spinale Effects of Deletion of the Matrix Metalloproteinase 9 Gene on Development of Murine Thoracic Aortic Aneurysms Circulation, August 30, 2005; 112(9_suppl): I-242 - I-248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Levine and E. Schwammenthal Ischemic Mitral Regurgitation on the Threshold of a Solution: From Paradoxes to Unifying Concepts Circulation, August 2, 2005; 112(5): 745 - 758. [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, C.-H. Tung, J. R. Allport, S. Chen, R. Weissleder, and P. L. Huang Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction Circulation, April 12, 2005; 111(14): 1800 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Deschamps, W. M. Yarbrough, C. E. Squires, R. A. Allen, D. M. McClister, K. B. Dowdy, J. E. McLean, J. T. Mingoia, J. A. Sample, R. Mukherjee, et al. Trafficking of the Membrane Type-1 Matrix Metalloproteinase in Ischemia and Reperfusion: Relation to Interstitial Membrane Type-1 Matrix Metalloproteinase Activity Circulation, March 8, 2005; 111(9): 1166 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, F. Lupu, S. Terclavers, B. Vanwetswinkel, J.-M. Herbert, A. Baker, D. Collen, P. Carmeliet, and L. Moons Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice Am. J. Pathol., January 1, 2005; 166(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Ikonomidis, J. W. Hendrick, A. M. Parkhurst, A. R. Herron, P. G. Escobar, K. B. Dowdy, R. E. Stroud, E. Hapke, M. R. Zile, and F. G. Spinale Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H149 - H158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Tibayan, F. Rodriguez, F. Langer, M. K. Zasio, L. Bailey, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Alterations in Left Ventricular Torsion and Diastolic Recoil After Myocardial Infarction With and Without Chronic Ischemic Mitral Regurgitation Circulation, September 14, 2004; 110(11_suppl_1): II-109 - II-114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohta, T. Nakajima, A. Y. L. Cheah, S. H. E. Zaidi, N. Kaviani, F. Dawood, X.-M. You, P. Liu, M. Husain, and M. Rabinovitch Elafin-overexpressing mice have improved cardiac function after myocardial infarction Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H286 - H292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mukherjee, A. M. Parkhurst, J. T. Mingoia, S. E. Sweterlitsch, J. S. Leiser, G. P. Escobar, F. G. Spinale, and J. P. Saul Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1242 - H1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Chapman and F. G. Spinale Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H1 - H10. [Full Text] [PDF]
|
|
|
|
|
|
F. A. Tibayan, F. Rodriguez, F. Langer, M. K. Zasio, L. Bailey, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller Annular remodeling in chronic ischemic mitral regurgitation: ring selection implications Ann. Thorac. Surg., November 1, 2003; 76(5): 1549 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Yarbrough, R. Mukherjee, G. P. Escobar, J. T. Mingoia, J. A. Sample, J. W. Hendrick, K. B. Dowdy, J. E. McLean, A. S. Lowry, T. P. O'Neill, et al. Selective Targeting and Timing of Matrix Metalloproteinase Inhibition in Post-Myocardial Infarction Remodeling Circulation, October 7, 2003; 108(14): 1753 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Villarreal, M. Griffin, J. Omens, W. Dillmann, J. Nguyen, and J. Covell Early Short-Term Treatment With Doxycycline Modulates Postinfarction Left Ventricular Remodeling Circulation, September 23, 2003; 108(12): 1487 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayashidani, H. Tsutsui, M. Ikeuchi, T. Shiomi, H. Matsusaka, T. Kubota, K. Imanaka-Yoshida, T. Itoh, and A. Takeshita Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1229 - H1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Wilson, S. L. Moainie, J. M. Baskin, A. S. Lowry, A. M. Deschamps, R. Mukherjee, T. S. Guy, M. G. St John-Sutton, J. H. Gorman III, L. H. Edmunds Jr, et al. Region- and Type-Specific Induction of Matrix Metalloproteinases in Post-Myocardial Infarction Remodeling Circulation, June 10, 2003; 107(22): 2857 - 2863. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||